Clinical trial
Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Roflumilast on Endothelial Function in Patients With Chronic Obstructive Pulmonary Disease
NCT01595750 is registered in ClinicalTrials.gov with Spanish Research Center for Respiratory Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Roflumilast on Endothelial Function in Patients With Chronic Obstructive Pulmonary Disease
- Lead sponsor
- Spanish Research Center for Respiratory Diseases
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- May 31, 2012
- Completion date
- August 31, 2012
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic obstructive pulmonary disease